LONG TERM REMISSION/SURVIVAL OVER 8 YEARS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 DENDRITIC CELL-BASED IMMUNOTHERAPY (PHASE I)

被引：0

作者：

Phuphanich, S. ^{[1
]}

Wheeler, C. ^{[1
]}

Rudnick, J. ^{[1
]}

Hu, J. ^{[1
]}

Mazer, M. ^{[1
]}

Nuno, M. ^{[1
]}

Sanchez, C. ^{[1
]}

Chu, R. ^{[1
]}

Black, K. ^{[1
]}

Yu, J. ^{[1
,2
]}

机构：

[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[2] ImmunoCellular Therapeut Ltd, Woodland Hills, CA USA

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OS2.5

引用

页码：5 / 5

页数：1

共 21 条

[1] LONG TERM REMISSION OVER 5 YEARS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 VACCINE: A FOLLOW UP STUDY
Phuphanich, Surasak
Wheeler, Christopher
Rudnick, Jeremy
Hu, Jethro
Mazer, Mia
Wang, Hong
Nuno, Miriam
Guevarra, Almar
Sanchez, Cherry
Fan, Xuemo
Ji, Jianfei
Chu, Ray
Bender, James
Hawkins, Elma
Black, Keith
Yu, John
NEURO-ONCOLOGY, 2013, 15 : 71 - 71
[2] TEN-YEAR FOLLOW UP WITH LONG TERM REMISSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 VACCINE (PHASE I)
Phuphanich, Surasak
Wheeler, Christopher
Rudnick, Jeremy
Hu, Jethro
Mazer, Mia
Sanchez, Cherry
Nuno, Miriam
Chu, Ray
Black, Keith
Yu, John
NEURO-ONCOLOGY, 2016, 18 : 23 - 23
[3] QUANTITATIVE ASSESSMENT OF HLA CLASS I PRESENTATION IN ICT-107, A DENDRITIC CELL-BASED IMMUNOTHERAPY
Kaabinejadian, Saghar
Buchli, Rico
Swanson, Steven J.
Gringeri, Anthony J.
Weidanz, Jon A.
Hildebrand, William H.
HUMAN IMMUNOLOGY, 2016, 77 : 8 - 8
[4] Prolonged Durable Progression-Free Survival in Newly Diagnosed Glioblastoma Following Dendritic Cell lmmunotherapy (ICT-107)
Phuphanich, Surasak
Rudnick, Jeremy
Wheeler, Christopher
Mazer, Maya
Richardson, Jaime
Hong Quing
Bender, James
Hawkins, Elma
Black, Keith
Yu, John
NEUROLOGY, 2011, 76 (09) : A98 - A98
[5] A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients
Wen, Patrick Y.
Reardon, David A.
Phuphanich, Surasak
Aiken, Robert
Landolfl, Joseph C.
Curry, William T.
Zhu, Jay-Jiguang
Glantz, Michael J.
Peereboom, David M.
Markert, James
LaRocca, Renato V.
O'Rourke, Donald
Fink, Karen L.
Kim, Lyndon J.
Gruber, Michael L.
Lesser, Glenn Jay
Pan, Edward
Kesari, Santosh
Hawkins, Elma S.
Yu, John
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[6] Glioma-associated antigens associated with prolonged survival in a phase I study of ICT-107 for patients with newly diagnosed glioblastoma.
Phuphanich, S.
Wheeler, C. J.
Rudnick, J.
Mazer, M.
Nuno, M.
Fan, X.
Bender, J.
Hawkins, E. S.
Black, K. L.
Yu, J.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[7] A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Wen, Patrick Y.
Reardon, David A.
Armstrong, Terri S.
Phuphanich, Surasak
Aiken, Robert D.
Landolfi, Joseph C.
Curry, William T.
Zhu, Jay-Jiguang
Glantz, Michael
Peereboom, David M.
Markert, James M.
LaRocca, Renato
O'Rourke, Donald M.
Fink, Karen
Kim, Lyndon
Gruber, Michael
Lesser, Glenn J.
Pan, Edward
Kesari, Santosh
Muzikansky, Alona
Pinilla, Clemencia
Santos, Radleigh G.
Yu, John S.
CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5799 - 5807
[8] A RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED PHASE 2 TRIAL OF DENDRITIC CELL (DC) VACCINE ICT-107 FOLLOWING STANDARD TREATMENT IN NEWLY DIAGNOSED PATIENTS WITH GBM
Wen, Patrick
Reardon, David
Phuphanich, Surasak
Aiken, Robert
Landolfi, Joseph
Curry, William
Zhu, Jay-Jiguang
Glantz, Michael
Peereboom, David
Markert, James
Larocca, Renato
O'Rourke, Donald
Fink, Karen
Kim, Lyndon
Gruber, Michael
Lesser, Glenn
Pan, Ed
Kesari, Santosh
Yu, John
NEURO-ONCOLOGY, 2014, 16
[9] Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
Ardon, Hilko
Van Gool, Stefaan
Lopes, Isabel Spencer
Maes, Wim
Sciot, Raf
Wilms, Guido
Demaerel, Philippe
Bijttebier, Patricia
Claes, Laurence
Goffin, Jan
Van Calenbergh, Frank
De Vleeschouwer, Steven
JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) : 261 - 272
[10] Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
Hilko Ardon
Stefaan Van Gool
Isabel Spencer Lopes
Wim Maes
Raf Sciot
Guido Wilms
Philippe Demaerel
Patricia Bijttebier
Laurence Claes
Jan Goffin
Frank Van Calenbergh
Steven De Vleeschouwer
Journal of Neuro-Oncology, 2010, 99 : 261 - 272

← 1 2 3 →